ストックスクリーナーアプリを入手
0.6665
3.07%
-0.0211
アフターアワーズ：
.62
-0.0465
-6.98%
前日終値:
$0.6876
開ける：
$0.71
24時間の取引高:
122.82K
Relative Volume:
0.25
時価総額：
$2.58M
収益：
$35.49M
当期純損益:
$-6.04M
株価収益率:
-0.0512
EPS:
-13.0191
ネットキャッシュフロー:
$-6.42M
1週間 パフォーマンス:
-20.90%
1か月 パフォーマンス:
-43.03%
6か月 パフォーマンス:
-93.59%
1年 パフォーマンス:
-95.59%
1日の値動き範囲:
$0.6665
$0.7488
1週間の範囲:
$0.6665
$0.85
52週間の値動き範囲:
$0.6665
$24.30
Sunshine Biopharma Inc Stock (SBFM) Company Profile
名前
Sunshine Biopharma Inc
セクター
電話
954-330-0684
住所
333 LAS OLAS WAY, FORT LAUDERDALE
Compare SBFM vs TAK, TEVA, HLN, ZTS, UTHR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SBFM
Sunshine Biopharma Inc
|
0.6665 | 3.27M | 35.49M | -6.04M | -6.42M | -13.02 |
TAK
Takeda Pharmaceutical Co Adr
|
17.86 | 60.23B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
39.53 | 45.71B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
8.80 | 40.72B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
69.69 | 29.36B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
541.70 | 20.39B | 3.17B | 1.29B | 1.01B | 27.09 |
Sunshine Biopharma Inc (SBFM) 最新ニュース
Shares traded below Nasdaq’s $1 minimum. Sunshine Biopharma (SBFM) has approved a possible reverse split. - Stock Titan
Sunshine Biopharma, Inc. (SBFM) Upgraded to Buy: Here's What You Should Know - Eastern Progress
Sunshine Biopharma, Inc. (SBFM) Stock Price, News, Quote & History - Yahoo! Finance Canada
SBFM Looks 59.3% Undervalued on GF Value™ Despite Distressed Fun - GuruFocus
Sunshine Biopharma launches generic ondansetron in Canada - Investing.com
Sunshine Biopharma launches generic ondansetron in Canada By Investing.com - Investing.com Nigeria
Sunshine Biopharma Launches Generic Zofran(R) in Canada, Expanding Oncology Supportive Care Portfolio - Corsicana Daily Sun
A generic drug for nausea during cancer treatment launches in Canada - Stock Titan
Sunshine Biopharma Inc (SBFM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Sunshine Biopharma Stock (SUNB) Opinions on Coronavirus Drug Studies - Quiver Quantitative
Sunshine Biopharma Authorizes Reverse Stock Split of Up to 1-for-20 - Minichart
Sunshine Biopharma CEO Authorizes Potential Reverse Stock Split - TipRanks
SBFM Looks 51.6% Undervalued on GF Value™ Despite Distressed Fun - GuruFocus
Sunshine Biopharma Advances Lead Coronavirus Drug Candidate into IND-Enabling Studies - Weatherford Democrat
An oral drug candidate suppressed lung virus in infected mice - Stock Titan
EXCLUSIVE: Sunshine Biopharma Advances 'Differentiated Antiviral Candidate' to IND-Enabling Studies - Yahoo Finance
Sunshine Biopharma Adjusts Series B Warrant Exercise Price - TipRanks
Form 8K Sunshine Biopharma Inc For: 11 September By Investing.com - Investing.com South Africa
Sunshine Biopharma reduces Series B warrant exercise price to $1.2046 By Investing.com - Investing.com South Africa
Sunshine Biopharma reduces Series B warrant exercise price to $1.2046 - Investing.com
Sunshine Biopharma (NASDAQ: SBFM) Anticipates $31M from Series B Warrant Exercises - kalkinemedia.com
Price to earnings forward of Sunshine Biopharma Inc. – BOATS:SBFMW - TradingView
Price to sales forward of Sunshine Biopharma Inc. – BOATS:SBFMW - TradingView
Sunshine Biopharma Inc. SEC Filing (Sep 9, 2026) - Stock Titan
Sunshine Biopharma Inc. (SBFM) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Sunshine Biopharma Inc. (SBFM) Peer Comparison – Compare with Others - Value Research
Sunshine Biopharma receives Canadian approval for atenolol tablets By Investing.com - Investing.com Nigeria
Sunshine Biopharma Announces Board Vacancy as Dr. Andrew Keller Steps Down After Term Ends - kalkinemedia.com
SBFM Looks 52.9% Undervalued on GF Value™ Despite Weak Fundamentals - GuruFocus
Health Canada Approves Sunshine Biopharma's Atenolol for Treating and Managing Cardiovascular Conditions - Cadillac News
Health Canada approves Atenolol, a drug used for high blood pressure and chest pain - Stock Titan
Sunshine Biopharma Inc. Warrant (SBFMW) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Sunshine Biopharma (NASDAQ: SBFM) could raise $31M from warrants - Stock Titan
Dr. Andrew Keller to Leave Sunshine Biopharma Board at Term End - TradingView
Sunshine Biopharma Inc. Announces Term Completion of Dr. Andrew Keller as Director - marketscreener.com
Sunshine Biopharma Reports In Vivo Tumor Suppression with K1.1 mRNA and Advances Novel mRNA-Cancer Vaccine Strategy for Lung Cancer - The Batesville Daily Guard
Sunshine Biopharma Inc. Warrant (SBFMW) Key Financial Ratios – Valuation, Profitability & More - Value Research
Sunshine (SBFMW) Market: Closes Nearly Flat at $0.05 in the Available Record; Levels: the Current Price Sits Inside the Supplied Technical RangeExhaustion Gap - vinanet.vn
Sunshine Biopharma wins Canadian approval for generic Enalapril tablets - Bitget
SBFM Looks 55.2% Undervalued on GF Value™ Despite Challenging Fu - GuruFocus
BRIEF-Sunshine Biopharma Receives Canadian Regulatory Approval For Enalapril - Bitget
Sunshine Biopharma receives Canadian approval for generic enalapril By Investing.com - Investing.com Canada
Sunshine Biopharma receives Canadian approval for generic enalapril - Investing.com
Sunshine Biopharma Receives Canadian Regulatory Approval for Enalapril, Expanding Into $25.94 Billion Global Anti-Hypertensive Drug Market - Eagle-Tribune
EXCLUSIVE: Sunshine Biopharma Secures Canadian Approval for Generic Hypertension Drug - Yahoo Finance
Sunshine (SBFM) Quarterly Performance Check: The Company Lists Its Latest Available Figures in the Reported Period; Session Reaction: The Stock Ends Up 1.79% in the Latest ReadingEarnings Momentum Score - vinanet.vn
101,973 Common Stock of Sunshine Biopharma, Inc. are subject to a Lock-Up Agreement Ending on 18-AUG-2026. - marketscreener.com
Sunshine Biopharma earnings beat by $0.05, revenue topped estimates - Investing.com
Sunshine Biopharma Inc (SBFM) 財務データ
収益
当期純利益
現金流量
EPS
1.15%
5.19%
大文字化:
|
ボリューム (24 時間):